학술논문

Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial
Document Type
Article
Source
In International Immunopharmacology 25 January 2024 127
Subject
Language
ISSN
1567-5769